ECV vs Navicare Biotech: monthly revenue

Monthly revenue and year-on-year change for ECV (6689) and Navicare Biotech (8472) over the past 13 months. The chart compares year-on-year growth rather than amounts, since the companies differ in size.

Year-on-year change

━ ECV ━ Navicare Biotech

0%+202%-28%25/1026/0126/0426/0726/10

Monthly revenue history

MonthECVYoYNavicare BiotechYoY
Oct 2026NT$1.23 billion+15.8%NT$51.5 million+0.8%
Sep 2026NT$1.13 billion+6.2%NT$45.2 million-28.1%
Aug 2026NT$1.19 billion+20.3%NT$55.6 million+121.3%
Jul 2026NT$1.33 billion+42.2%NT$48.1 million+5.6%
Jun 2026NT$1.07 billion+4.4%NT$47.5 million-20.7%
May 2026NT$1.03 billion-0.3%NT$38.6 million+7.3%
Apr 2026NT$1.02 billion-11.2%NT$39.8 million-11.8%
Mar 2026NT$1.03 billion-8.2%NT$47.3 million+11.1%
Feb 2026NT$913.4 million-11.0%NT$47 million+202.3%
Jan 2026NT$1.05 billion+0.5%NT$28.5 million+30.8%
Dec 2025NT$1.04 billion-15.5%NT$41.3 million+39.8%
Nov 2025NT$969 million-14.1%NT$30.9 million-4.8%
Oct 2025NT$1.06 billion-10.1%NT$51 million+128.1%

← All Taiwan listed & OTC companies

Sources: Taiwan Stock Exchange, monthly revenue of listed companies (Government Open Data Platform); Taipei Exchange, monthly revenue of OTC companies (TPEx OpenAPI); historical months from MOPS. Amounts in New Taiwan dollars. Changes calculated by this site from the source figures. Not investment advice. Updated: 2026-11-16